Post Conference Review and Analysis
AcademicCME covered the topic of polycythemia vera, highlighting and analyzing data presented at the American Society of Hematology (ASH) Annual Meeting & Exposition from December 3 – 6, 2016 in San Diego, California.
A CME initiative was developed to educate healthcare providers involved in the management of patients with polycythemia vera, particularly in regard to utilizing JAK inhibitor therapeutics, to relay best practices and optimal strategies for improving patient outcomes.
A Clinical Overview of JAK Inhibitor Therapeutics for the Management of Patients with Polycythemia Vera
Post-Conference Review and Analysis On-Demand Webcast from the 58th American Society of Hematology (ASH) Annual Meeting & Exposition.
1.00 AMA PRA Category 1 Credit(s)™
Provided by AcademicCME
Supported by an independent educational grant from Incyte Corporation.